SNTI — Senti Biosciences Holdings, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1854270 ·
Last close
$0.34
Market Cap
$10.62M
52W High
$1.15
52W Low
$0.34
ADV30
324,600
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 16,000 | — | -11,498,000 | -4,221,000 | 38,241,000 | 8,935,000 | 35,676,000 |
| Dec 2025 | 22,000 | — | -13,584,000 | -14,467,000 | 51,223,000 | 16,420,000 | 45,634,000 |
| Sep 2025 | 0 | — | -16,948,000 | -18,126,000 | 52,685,000 | 12,243,000 | 44,564,000 |
| Jun 2025 | 0 | — | -16,798,000 | -14,733,000 | 68,540,000 | 21,576,000 | 43,888,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-36,875,000
Investing CF
$-70,000
Financing CF
$12,057,000
CapEx
$-11,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.92
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-362,793,000
Inventory
—
Receivables
$765,000
ST Investments
—
EBIT TTM
$-58,828,000
Pretax Income TTM
$-51,547,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$38,000
EBITDA
$-51,639,000
Free Cash Flow
$-17,241,750
Enterprise Value
$20,618,788
Total Cash
$9,127,000
Total Debt
$19,141,000
Shares Out
31,144,754
Trailing EPS
$-1.46
Book Value
$0.08
ROE
-255.0%
ROA
-56.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 22,000 | -63,727,000 | -61,438,000 | 51,223,000 | 45,634,000 | — | -43,444,000 |
| Dec 2024 | 0 | -60,726,000 | -52,790,000 | 97,841,000 | 72,192,000 | — | -41,397,000 |
| Dec 2023 | 1,978,000 | -66,765,000 | -71,058,000 | 119,484,000 | 52,571,000 | — | -52,395,000 |
| Dec 2022 | 3,286,000 | -62,084,000 | -58,210,000 | 180,792,000 | 53,529,000 | — | -34,896,000 |
TTM Snapshot
Revenues TTM
$3,207,000
NetIncome TTM
$-54,172,000
OpCashFlow TTM
$0
Assets (Latest)
$97,841,000
Forward EPS
$-0.95
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INTS | INTENSITY THERAPEUTICS, INC. | $11.22M | $4.15 | — |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | $9.93M | $0.90 | — |
| INAB | IN8BIO, INC. | $9.93M | $1.03 | — |
| CUBT | Curative Biotechnology Inc | $9.90M | $1.29 | — |
| CRIS | CURIS INC | $9.78M | $5.02 | — |
News headlines (Yahoo Finance, 1h cache)
Senti Biosciences Holdings, Inc. Announces a Strategic Transaction to Unlock Value for its Gene-Circuit-Enabled Pipeline, Including SENTI-202, and to Sharpen its Focus on Next-Generation Controllable
2026-07-15 11:30 · Yahoo
Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
2026-05-14 12:45 · Yahoo
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Update
2026-05-14 12:40 · Yahoo
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
2026-04-13 13:00 · Yahoo
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
2026-04-01 12:45 · Yahoo
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
2026-03-27 12:00 · Yahoo
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference
2026-03-23 13:00 · Yahoo
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference
2026-03-03 14:05 · Yahoo
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference
2026-02-24 14:15 · Yahoo
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development
2026-02-20 13:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.